| Name | Title | Contact Details |
|---|
DermaMed Solutions helps spa owners, dermatologists, plastic surgeons and other skin care and medical professionals expand their practices to include additional services. Entrepreneur Roger Parkin founded our company in 1998. Inspiration came when an aesthetician suggested he develop a quieter microdermabrasion machine. The result was MegaPeel®. Besides being quieter than similar devices, our microdermabrasion system was smaller, was easier to use and reduced troublesome vibrations.
Surgical Orthomedics, Inc. is a Pantego, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Sammons Preston Inc is a Bolingbrook, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
AliveCor, Inc. is pioneering the creation of FDA-cleared machine learning techniques to enable proactive heart care and is recognized around the world for transforming cardiac care. The FDA-cleared KardiaMobile is the most clinically validated mobile EKG solution on the market. It is recommended by leading cardiologists and used by people worldwide for accurate EKG recordings. KardiaMobile, and KardiaBand, when paired with the Kardia app provide instant analysis for detecting atrial fibrillation (AF) and normal sinus rhythm in an EKG. Kardia is the first A.I. enabled platform to help clinicians manage patients for the early detection of atrial fibrillation, the most common cardiac arrhythmia and one that leads to a five times greater risk of stroke. KardiaBand is the first FDA-cleared medical device accessory for Apple Watch. AliveCor is recognized by FastCompany as 2018`s No. 1 most innovative company in artificial intelligence. AliveCor is a privately-held venture backed company headquartered in Mountain View, Calif.
RF Surgical Systems, Inc. is a medical device company with headquarters in Bellevue, Washington and engineering R & D facilities in San Diego, California. The advanced technologies used in the RF Surgical Detection System are protected by U.S. patents. Regulatory clearance to market the system was granted by the U.S. Food and Drug Administration in November of 2006